Copyright Reports & Markets. All rights reserved.

Global Meningococcal Disease Drugs Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Meningococcal Disease Drugs

      • 1.1 Definition of Meningococcal Disease Drugs
      • 1.2 Meningococcal Disease Drugs Segment by Type
        • 1.2.1 Global Meningococcal Disease Drugs Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Injectable
        • 1.2.3 Oral
      • 1.3 Meningococcal Disease Drugs Segment by Applications
        • 1.3.1 Global Meningococcal Disease Drugs Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospitals
        • 1.3.3 Drugstores
        • 1.3.4 Others
      • 1.4 Global Meningococcal Disease Drugs Overall Market
        • 1.4.1 Global Meningococcal Disease Drugs Revenue (2014-2025)
        • 1.4.2 Global Meningococcal Disease Drugs Production (2014-2025)
        • 1.4.3 North America Meningococcal Disease Drugs Status and Prospect (2014-2025)
        • 1.4.4 Europe Meningococcal Disease Drugs Status and Prospect (2014-2025)
        • 1.4.5 China Meningococcal Disease Drugs Status and Prospect (2014-2025)
        • 1.4.6 Japan Meningococcal Disease Drugs Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Meningococcal Disease Drugs Status and Prospect (2014-2025)
        • 1.4.8 India Meningococcal Disease Drugs Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Meningococcal Disease Drugs
      • 2.3 Manufacturing Process Analysis of Meningococcal Disease Drugs
      • 2.4 Industry Chain Structure of Meningococcal Disease Drugs

      3 Development and Manufacturing Plants Analysis of Meningococcal Disease Drugs

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Meningococcal Disease Drugs Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Meningococcal Disease Drugs
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Meningococcal Disease Drugs Production and Capacity Analysis
      • 4.2 Meningococcal Disease Drugs Revenue Analysis
      • 4.3 Meningococcal Disease Drugs Price Analysis
      • 4.4 Market Concentration Degree

      5 Meningococcal Disease Drugs Regional Market Analysis

      • 5.1 Meningococcal Disease Drugs Production by Regions
        • 5.1.1 Global Meningococcal Disease Drugs Production by Regions
        • 5.1.2 Global Meningococcal Disease Drugs Revenue by Regions
      • 5.2 Meningococcal Disease Drugs Consumption by Regions
      • 5.3 North America Meningococcal Disease Drugs Market Analysis
        • 5.3.1 North America Meningococcal Disease Drugs Production
        • 5.3.2 North America Meningococcal Disease Drugs Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Meningococcal Disease Drugs Import and Export
      • 5.4 Europe Meningococcal Disease Drugs Market Analysis
        • 5.4.1 Europe Meningococcal Disease Drugs Production
        • 5.4.2 Europe Meningococcal Disease Drugs Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Meningococcal Disease Drugs Import and Export
      • 5.5 China Meningococcal Disease Drugs Market Analysis
        • 5.5.1 China Meningococcal Disease Drugs Production
        • 5.5.2 China Meningococcal Disease Drugs Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Meningococcal Disease Drugs Import and Export
      • 5.6 Japan Meningococcal Disease Drugs Market Analysis
        • 5.6.1 Japan Meningococcal Disease Drugs Production
        • 5.6.2 Japan Meningococcal Disease Drugs Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Meningococcal Disease Drugs Import and Export
      • 5.7 Southeast Asia Meningococcal Disease Drugs Market Analysis
        • 5.7.1 Southeast Asia Meningococcal Disease Drugs Production
        • 5.7.2 Southeast Asia Meningococcal Disease Drugs Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Meningococcal Disease Drugs Import and Export
      • 5.8 India Meningococcal Disease Drugs Market Analysis
        • 5.8.1 India Meningococcal Disease Drugs Production
        • 5.8.2 India Meningococcal Disease Drugs Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Meningococcal Disease Drugs Import and Export

      6 Meningococcal Disease Drugs Segment Market Analysis (by Type)

      • 6.1 Global Meningococcal Disease Drugs Production by Type
      • 6.2 Global Meningococcal Disease Drugs Revenue by Type
      • 6.3 Meningococcal Disease Drugs Price by Type

      7 Meningococcal Disease Drugs Segment Market Analysis (by Application)

      • 7.1 Global Meningococcal Disease Drugs Consumption by Application
      • 7.2 Global Meningococcal Disease Drugs Consumption Market Share by Application (2014-2019)

      8 Meningococcal Disease Drugs Major Manufacturers Analysis

      • 8.1 Pfizer
        • 8.1.1 Pfizer Meningococcal Disease Drugs Production Sites and Area Served
        • 8.1.2 Pfizer Product Introduction, Application and Specification
        • 8.1.3 Pfizer Meningococcal Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 GlaxoSmithKline
        • 8.2.1 GlaxoSmithKline Meningococcal Disease Drugs Production Sites and Area Served
        • 8.2.2 GlaxoSmithKline Product Introduction, Application and Specification
        • 8.2.3 GlaxoSmithKline Meningococcal Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Sanofi Pasteur
        • 8.3.1 Sanofi Pasteur Meningococcal Disease Drugs Production Sites and Area Served
        • 8.3.2 Sanofi Pasteur Product Introduction, Application and Specification
        • 8.3.3 Sanofi Pasteur Meningococcal Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Novartis
        • 8.4.1 Novartis Meningococcal Disease Drugs Production Sites and Area Served
        • 8.4.2 Novartis Product Introduction, Application and Specification
        • 8.4.3 Novartis Meningococcal Disease Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served

      9 Development Trend of Analysis of Meningococcal Disease Drugs Market

      • 9.1 Global Meningococcal Disease Drugs Market Trend Analysis
        • 9.1.1 Global Meningococcal Disease Drugs Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Meningococcal Disease Drugs Regional Market Trend
        • 9.2.1 North America Meningococcal Disease Drugs Forecast 2019-2025
        • 9.2.2 Europe Meningococcal Disease Drugs Forecast 2019-2025
        • 9.2.3 China Meningococcal Disease Drugs Forecast 2019-2025
        • 9.2.4 Japan Meningococcal Disease Drugs Forecast 2019-2025
        • 9.2.5 Southeast Asia Meningococcal Disease Drugs Forecast 2019-2025
        • 9.2.6 India Meningococcal Disease Drugs Forecast 2019-2025
      • 9.3 Meningococcal Disease Drugs Market Trend (Product Type)
      • 9.4 Meningococcal Disease Drugs Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Meningococcal Disease Drugs Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Meningococcal disease is a severe infection of meninges, the thin layers of tissue covering brain and spinal cord, caused by the bacteria Neisseria meningitidis. This bacteria can also cause bloodstream infections (septicemia). Bacterial meningitis is severe because of rapid onset and a significant risk of death associated with infection. Infection of Neisseria meningitidis may also result in mental retardation, deafness and epilepsy. 12 strains of N. meningitidis have been identified, 6 of which (A, B, C, W, X and Y) are capable enough to cause epidemics. Meningococcal septicaemia is a rare but fatal form of meningococcal disease characterized by a haemorrhagic rash and rapid circulatory collapse.

        The global Meningococcal Disease Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Meningococcal Disease Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Meningococcal Disease Drugs market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Meningococcal Disease Drugs in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Meningococcal Disease Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Pfizer
        GlaxoSmithKline
        Sanofi Pasteur
        Novartis 
        ...

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Injectable
        Oral

        Segment by Application
        Hospitals
        Drugstores
        Others

        Buy now